Signant Health, a provider of a clinical trial management platform, has appointed Paul Richmond as its chief commercial officer.
In his new role at Signant Health, Richmond will lead the commercial team and guide customers in selecting solutions suited to their protocol, disease area, and evidence-generation strategies.
Prior to joining Signant Health, he served as the senior vice president and global head of the commercial clinical research division at PPD, a global contract research organization (CRO), where he held pivotal roles for 14 years.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.